Capitalize on the Industry’s Momentum & Solidify Your Role in Advancing Pulmonary Fibrosis Therapeutics to Patients
The pulmonary fibrosis landscape is undergoing rapid transformation.
With recent clinical breakthroughs reshaping expectations for efficacy and multiple late-stage assets soon to be entering the market, drug developers are now operating in a far more complex, competitive, and fast-moving environment. The challenge is no longer simply advancing new therapies, but differentiating them, designing smarter trials, and generating clearer, earlier signals of success.
This shift is driving a growing demand for innovative partners who can help de-risk development and improve decision-making across the pipeline.
The 10th IPF Summit brings together the full ecosystem of IPF and progressive fibrotic ILD drug development, creating a highly focused forum where these challenges are actively being addressed.
Across discovery, translational science, and clinical development, attendees are seeking solutions in predictive disease modeling, biomarker-driven stratification, endpoint optimization, advanced imaging, and efficient clinical trial design.
For solution providers, this is a unique opportunity to be embedded directly in the conversations shaping the next generation of IPF therapeutics.
By engaging with senior decision-makers at the point of strategic need, you can demonstrate how your capabilities directly address the field's most pressing challenges today.
“Breadth of content covering everything happening in IPF and related diseases. Access to key people and support to make introductions in such a small area.”
Qureight
What to Expect
Unlock High-Value Partnerships
Engage directly with senior decision-makers actively progressing IPF pipelines. Through curated networking formats, including targeted 1:1 introductions and structured sessions, build meaningful relationships that convert into tangible business opportunities.
Elevate Your Brand With a Highly Targeted Audience
Gain consistent visibility among a concentrated group of IPF leaders and innovators. From pre-event promotion through to on-site engagement, reinforce your brand as a trusted and credible partner in advancing fibrosis therapeutics.
Differentiate Your Expertise in a Competitive Market
Position your capabilities at the forefront of IPF drug development by demonstrating how your solutions solve critical challenges, whether in preclinical models, biomarker strategies, imaging, or clinical execution. Stand out as a strategic partner, not just a provider.
Showcase Your Solutions With Real Impact
Bring your offering to life through a dedicated exhibition presence designed to drive interaction and engagement. Create memorable, hands-on experiences that clearly demonstrate your value and leave a lasting impression on prospective partners.
Key Services & Solutions in Need:
Our attendees from respiratory focused biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:
Preclinical Model Providers with Deep Expertise in Recapitulating Human Lung Fibrosis
Providers developing next-generation in vivo and ex vivo platforms that closely emulate the lung microenvironment and disease trajectory to improve translatability from bench to bedside
Advanced Imaging & Diagnostic Tool Developers Supporting Early & Ongoing Disease Insights
Companies offering cutting-edge technologies, from imaging systems to digital screening solutions, that enable timely diagnosis, track disease evolution, and evaluate therapeutic outcomes and efficacy
Comprehensive Biomarker Platform Partners from Discovery to Deployment
Partners offering robust biomarker development, spanning validated, minimally invasive, and exploratory markers, to support patient stratification, disease monitoring, and therapeutic response
Preclinical CROs with Expertise in Fibrosis Mechanisms & Early Target Assessment
Research organizations with strong capabilities in fibrosis biology, supporting target identification, validation, and translational assay development to de-risk discovery efforts
Clinical CROs with Proven Competency in IPF & ILD Trials
Specialist CROs experienced in navigating rare lung disease trials, offering strategic input on study design, operational support for recruitment and site management, and expertise in meeting regulatory demands
Available Inventory:
At the IPF Summit, no two partnerships are the same. We work with you to understand your business development goals, ensuring you meet who you want to meet and how you want to meet them, getting the most out of this opportunity.
Our Bespoke Partnership Opportunities Can Include:
2026 Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Oliver Smare
Partnerships Director
Showcase Your Capabilities
Explore our bespoke sponsorship options include branding, presenting, and exhibiting to build a package tailored to you and your company's goals.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Maintain Your Competitive Edge
Cement your position in a competitive market ensuring your brand is at the heart of biopharma discussions.